Position in CADL
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$53,836,382
+$7,312,594 QoQ
Shares Held
10,987,017
+33.4% QoQ
Ownership
15.0%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2021
17 quarters on record
Voting authority
Sole 99.98877766367342.ToString("F0")%
Shared 0.ToString("F0")%
None 0.011222336326593469.ToString("F0")%
Common Shares in CADL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026FMR LLC holds $49,682,018,247 across 354 Biotechnology names. CADL ranks #98 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
14,579,166 | $4,823,808,652 | |
| 2 | ARGX |
Argenx SE
|
4,991,034 | $3,644,702,577 | |
| 3 | MRNA |
Moderna, Inc.
|
45,672,024 | $2,320,138,818 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
77,981,253 | $2,160,080,705 | |
| 5 | INSM |
INSMED Inc
|
13,160,167 | $2,151,950,504 | |
| 6 | IONS |
Ionis Pharmaceuticals Inc
|
24,556,637 | $1,843,957,869 | |
| 7 | RPRX |
Royalty Pharma plc
|
25,152,242 | $1,206,553,046 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,518,192 | $1,173,015,865 |
All Filings in CADL
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $53,836,382 | 10,987,017 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $46,523,788 | 8,234,299 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $41,990,263 | 8,233,385 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $41,661,180 | 8,233,435 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $40,032,035 | 7,085,316 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $34,056,839 | 3,923,599 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $45,550 | 6,573 | Shares | Defined | 2024-11-13 | |
| 2023-12-31 | $438,624 | 298,384 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $403,933 | 439,058 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $570,221 | 452,557 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $827,761 | 613,157 | Shares | Defined | 2023-08-11 | |
| 2022-12-31 | $1,320,296 | 737,596 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $2,824,112 | 899,399 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $2,914,052 | 899,399 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $10,038,630 | 1,972,226 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $17,695,424 | 2,262,842 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $27,100,000 | 2,500,000 | Shares | Defined | 2022-02-14 | |
| No filing history on record for this holder in this stock. | ||||||